Research Library

In the fight against Mexican criminal cartels, social network analysis can predict and map out their alliances and subgroups — using algorithms to predict new connections. In this commentary, Nonresident Scholar in Drug Policy and Mexico Studies Nathan P. Jones and his co-authors outline their recent work in the field.

Drug companies that bypass distributors and offer generics directly to patients, like the Mark Cuban Cost Plus Drug Company, could disrupt the pharmaceutical supply chain and ultimately save thousands of lives.

Texans served by regulated electricity markets, especially by electric cooperatives, were much more satisfied with their providers’ performance during Winter Storm Uri than those in deregulated markets. In this post for the Baker Institute Blog, the authors offer possible explanations for the contrast in favorability.

An overview of the ABA's Cannabis Law & Policy Committee, which is composed of attorneys across North America who have various mainstream practices and who seek to be stewards of historic changes in the pioneering field of marijuana law.

"This pandemic and looming economic crisis will affect all of us ... The sooner we relearn how to set aside our differences and unite during this difficult moment, the stronger we will emerge from it," writes former Secretary James A. Baker, III.

Coronavirus cases in Texas may grow as the state expands COVID-19 screening and the consequences of delayed decisions to limit public interactions set in. "No one should be surprised lim or panic as the figures roll out," write the authors in the Baker Institute Blog.

In the second of a series of blogs on the coronovirus outbreak, the authors sound a note of cautious optimism: "We hope for a relatively optimistic outlook for the COVID-19 pandemic in the United States, with the quick realization of all modifying interventions: earlier and broader testing, strict preventive hygienic and societal measures, a safe and effective vaccine, and effective therapies to treat the virus."  Read more at the Baker Institute Blog.

The COVID-19 outbreak has now reached pandemic proportions, threatening the health of millions worldwide and adversely affecting the international economy. Understanding the status of COVID-19, its potential impact in the U.S., and the needed preventive measures could save many lives.

Products containing hemp extracts high in CBD are gaining mainstream popularity, acceptance and federal legality. In this article, Lisa Pittman, nonresident fellow in drug policy, focuses on litigation issues particular to hemp.

According to the authors, as a leading agricultural state, Texas is poised to become the new leader in hemp production, whether for medicinal or industrial purposes.